Oral News and Research

RSS

Research links SARS-CoV-2 prevalence, hospital surfaces and patient microbiomes

Researchers found a higher bacterial diversity in SARS-CoV-2 patient rooms and surfaces in the room, suggesting bacterial diversity may play a role in virus transmission.

24 Nov 2020

Researchers conduct aerosol characterization experiments to protect healthcare workers from COVID-19

The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many requiring ventilators and other critical care. Such conditions can put medical workers at risk. Now researchers are studying methods to increase hospital safety and efficacy during the pandemic.

24 Nov 2020

MyMaskFit receives Innovate UK funding to produce custom-fitted, medical grade facemasks

A company working with experts from the University of Birmingham and King's College London has been awarded funding by Innovate UK to produce custom-fitted, reusable, medical grade facemasks that will fit all people regardless of age, sex or ethnicity.

23 Nov 2020

FDA expands approved indication for influenza treatment to include post-exposure prevention

Today, the U.S. Food and Drug Administration expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.

23 Nov 2020

New hydrogel can help with dry mouth relief

A team of scientists from the University of Leeds have developed a new hydrogel that has significant potential for oral care products that can help with dry mouth relief.

22 Nov 2020

Food products are potential SARS-CoV-2 carriers, study finds

A team of scientists at the Shahid Beheshti University of Medical Sciences and the Food Safety Research Center in Iran has emphasized the risk of various staple food products, including meat, dairy, fruits, vegetables, and ready-to-eat foods, as potential carriers of SARS-CoV-2 transmission.

20 Nov 2020

Researchers develop nasal spray against COVID-19 virus

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using materials already cleared for use in humans.

20 Nov 2020

Pork consumption is not likely to cause COVID-19 infection

According to the current state of knowledge, there are no cases that have shown evidence of humans being infected with the novel coronavirus via the consumption of contaminated food.

20 Nov 2020

New combination treatment for recurrent ovarian cancer shows positive outcomes

A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.

19 Nov 2020

Study describes the early evolution of oral poliovirus vaccine

While the world reels from the spread of SARS-CoV2, the new coronavirus behind COVID-19, a much older and previously feared scourge--poliovirus--is close to being completely eradicated.

19 Nov 2020

Domestic cats can be asymptomatic carriers of SARS-CoV-2, show studies

Two recently published studies from Kansas State University researchers and collaborators have led to two important findings related to the COVID-19 pandemic: Domestic cats can be asymptomatic carriers of SARS-CoV-2, but pigs are unlikely to be significant carriers of the virus. SARS-CoV-2 is the coronavirus responsible for COVID-19.

19 Nov 2020

Examining potential foodborne transmission of SARS-CoV-2 through fresh produce

To address this gap in knowledge, researchers from the Bureau of Microbial Hazards, Health Canada, and Faculty of Medicine, University of Ottawa examined the survival of human coronaviruses on the surface of fresh produce such as apples, cucumbers, and tomatoes.

18 Nov 2020

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

A team of researchers at the University of São Paulo in Brazil aimed to determine if vitamin D3 supplementation reduces the length of stay in hospitalized patients with severe COVID-19.

18 Nov 2020

Investigational drug helped improve heart health in patients with chronic conditions

The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's Division of Cancer Diagnosis and Treatment, part of the National Institutes of Health, have shown that the immunotherapy combination of ipilimumab and nivolumab shrinks rare angiosarcoma tumors in 25 percent of all patients, with some having an even stronger response to the drug combination.

15 Nov 2020

Elastic-free facial masks could benefit individuals with contact dermatitis during COVID-19

A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible allergic reactions.

15 Nov 2020

Arthritis drug may improve COVID-19 survival among elderly patients

A type of arthritis drug may reduce the risk of dying for elderly patients with COVID-19.

15 Nov 2020

WHO approves first ever vaccine for emergency use to address polio

WHO today listed the nOPV2 vaccine (Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries.

15 Nov 2020

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Oral News and Research

Research links SARS-CoV-2 prevalence, hospital surfaces and patient microbiomes

Researchers conduct aerosol characterization experiments to protect healthcare workers from COVID-19

MyMaskFit receives Innovate UK funding to produce custom-fitted, medical grade facemasks

FDA expands approved indication for influenza treatment to include post-exposure prevention

New hydrogel can help with dry mouth relief

Food products are potential SARS-CoV-2 carriers, study finds

Researchers develop nasal spray against COVID-19 virus

Pork consumption is not likely to cause COVID-19 infection

New combination treatment for recurrent ovarian cancer shows positive outcomes

Study describes the early evolution of oral poliovirus vaccine

Domestic cats can be asymptomatic carriers of SARS-CoV-2, show studies

Examining potential foodborne transmission of SARS-CoV-2 through fresh produce

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

Investigational drug helped improve heart health in patients with chronic conditions

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Elastic-free facial masks could benefit individuals with contact dermatitis during COVID-19

Arthritis drug may improve COVID-19 survival among elderly patients

WHO approves first ever vaccine for emergency use to address polio

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News